
Bausch Health Companies Inc BHC.TO is expected to show a rise in quarterly revenue when it reports results on July 30 for the period ending June 30 2025
The Laval Quebec-based company is expected to report a 3.9% increase in revenue to $2.496 billion from $2.4 billion a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Bausch Health Companies Inc is for earnings of 97 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | 0.80 | 0.79 | 0.60 | Missed | -24.4 |
Dec. 31 2025 | 1.18 | 1.19 | 1.15 | Missed | -3.4 |
Sep. 30 2024 | 1.04 | 1.06 | 1.13 | Beat | 7 |
Jun. 30 2024 | 0.87 | 0.88 | 0.89 | Beat | 1.5 |
Mar. 31 2024 | 0.73 | 0.72 | 0.60 | Missed | -16.4 |
Dec. 31 2023 | 1.01 | 1.00 | 1.15 | Beat | 14.5 |
Sep. 30 2023 | 0.92 | 0.90 | 1.02 | Beat | 13.9 |
Jun. 30 2023 | 0.76 | 0.76 | 0.82 | Beat | 7.6 |
This summary was machine generated July 28 at 20:41 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)